Litcius/Paper detail

Deceptive and open-label placebo effects in experimentally induced guilt: a randomized controlled trial in healthy subjects

Dilan Sezer, Cosima Locher, Jens Gaab

2022Scientific Reports11 citationsDOIOpen Access PDF

Abstract

Placebos are known to yield significant effects in many conditions. We examined deceptive and open-label placebo effects on guilt, which is important for self-regulation and a symptom of mental disorders. Following an experimental induction of guilt, healthy subjects were randomized to deceptive placebo (DP; n = 35), open-label placebo (OLP; n = 35), or no treatment (NT; n = 39). The primary outcome was guilt responses assessed in area under the curve (AUC). Secondary outcomes were shame, guilt, and affect. We hypothesized that DP and OLP would reduce guilt compared to NT. Guilt responses were higher in the NT group than in the placebo groups (estimate = 2.03, 95% CI = 0.24-3.82, d = 0.53), whereas AUC guilt did not differ significantly between the placebo groups (estimate = -0.38, 95% CI = -2.52-1.76, d = -0.09). Placebos are efficacious in reducing acute guilt responses, regardless of the placebo administration (i.e., open vs. deceptive). Furthermore, we observed narrative-specific effects with significant changes of guilt but not shame, pride, or affect. These results indicate not only that guilt is amenable to placebos but also that placebos can be administered in an ethical and potentially emotion-specific manner.

Topics & Concepts

Randomized controlled trialPlaceboOpen labelMedicinePhysical medicine and rehabilitationInternal medicinePsychologyAlternative medicinePathologyPain Management and Placebo EffectPsychological Treatments and AssessmentsMindfulness and Compassion Interventions
Deceptive and open-label placebo effects in experimentally induced guilt: a randomized controlled trial in healthy subjects | Litcius